These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 12160938)

  • 1. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.
    Castegna A; Aksenov M; Aksenova M; Thongboonkerd V; Klein JB; Pierce WM; Booze R; Markesbery WR; Butterfield DA
    Free Radic Biol Med; 2002 Aug; 33(4):562-71. PubMed ID: 12160938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.
    Castegna A; Aksenov M; Thongboonkerd V; Klein JB; Pierce WM; Booze R; Markesbery WR; Butterfield DA
    J Neurochem; 2002 Sep; 82(6):1524-32. PubMed ID: 12354300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease.
    Boyd-Kimball D; Castegna A; Sultana R; Poon HF; Petroze R; Lynn BC; Klein JB; Butterfield DA
    Brain Res; 2005 May; 1044(2):206-15. PubMed ID: 15885219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein oxidation in the brain in Alzheimer's disease.
    Aksenov MY; Aksenova MV; Butterfield DA; Geddes JW; Markesbery WR
    Neuroscience; 2001; 103(2):373-83. PubMed ID: 11246152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic identification of nitrated proteins in Alzheimer's disease brain.
    Castegna A; Thongboonkerd V; Klein JB; Lynn B; Markesbery WR; Butterfield DA
    J Neurochem; 2003 Jun; 85(6):1394-401. PubMed ID: 12787059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of oxidatively modified proteins in Alzheimer's disease brain: insights into neurodegeneration.
    Butterfield DA; Castegna A
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):747-51. PubMed ID: 14528911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative modification of creatine kinase BB in Alzheimer's disease brain.
    Aksenov M; Aksenova M; Butterfield DA; Markesbery WR
    J Neurochem; 2000 Jun; 74(6):2520-7. PubMed ID: 10820214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
    Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Merchant M; Markesbery WR; Butterfield DA
    Neurobiol Aging; 2006 Nov; 27(11):1564-76. PubMed ID: 16271804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
    Sultana R; Perluigi M; Butterfield DA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics.
    Butterfield DA; Perluigi M; Sultana R
    Eur J Pharmacol; 2006 Sep; 545(1):39-50. PubMed ID: 16860790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of brain proteins in the gracile axonal dystrophy (gad) mouse, a syndrome that emanates from dysfunctional ubiquitin carboxyl-terminal hydrolase L-1, reveals oxidation of key proteins.
    Castegna A; Thongboonkerd V; Klein J; Lynn BC; Wang YL; Osaka H; Wada K; Butterfield DA
    J Neurochem; 2004 Mar; 88(6):1540-6. PubMed ID: 15009655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders.
    Aksenova MV; Aksenov MY; Payne RM; Trojanowski JQ; Schmidt ML; Carney JM; Butterfield DA; Markesbery WR
    Dement Geriatr Cogn Disord; 1999; 10(2):158-65. PubMed ID: 10026391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics identification of carbonylated and HNE-bound brain proteins in Alzheimer's disease.
    Sultana R; Butterfield DA
    Methods Mol Biol; 2009; 566():123-35. PubMed ID: 20058169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders.
    Poon HF; Farr SA; Thongboonkerd V; Lynn BC; Banks WA; Morley JE; Klein JB; Butterfield DA
    Neurochem Int; 2005 Jan; 46(2):159-68. PubMed ID: 15627516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma.
    Tezel G; Yang X; Cai J
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3177-87. PubMed ID: 16123417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer's disease mice at its earliest pathological stage.
    Shen L; Chen C; Yang A; Chen Y; Liu Q; Ni J
    J Proteomics; 2015 Jun; 123():101-13. PubMed ID: 25890254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.
    Butterfield DA; Poon HF; St Clair D; Keller JN; Pierce WM; Klein JB; Markesbery WR
    Neurobiol Dis; 2006 May; 22(2):223-32. PubMed ID: 16466929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer's disease.
    Choi J; Forster MJ; McDonald SR; Weintraub ST; Carroll CA; Gracy RW
    Free Radic Biol Med; 2004 May; 36(9):1155-62. PubMed ID: 15082069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain.
    Butterfield DA
    Brain Res; 2004 Mar; 1000(1-2):1-7. PubMed ID: 15053946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.